Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Susan Gregurick Previews Potential Elements of NIH’s Next Strategic Plan for Data Science

    Jun 28, 2022, 01:00 AM by User Not Found
    Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, Susan Gregurick, Associate Director for Data Science and Director of the Office of Data Science Strategy at the National Institutes of Health, gave a peek into what’s coming in the next iteration of the NIH Strategic Plan for Data Science.
    Full story
  • Cotiviti to Share Expertise on the Role of Quality in Improving Healthcare Outcomes at RISE Qualipalooza Conference

    Jun 27, 2022, 10:48 AM by
    Senior Vice President Rachael Jones to co-chair RISE event focused on improving quality of care and member experience
    Full story
  • ObvioHealth announces a groundbreaking partnership with Dedalus Group to unite real world & clinical trial data

    Jun 27, 2022, 10:48 AM by
    ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.
    Full story
  • Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

    Jun 27, 2022, 10:48 AM by
    On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience
    Full story
  • MicrobioSeq Boosts Microbial Diversity Research with Eukaryotic 18S rRNA Sequencing

    Jun 27, 2022, 10:47 AM by
    Full story
  • Amerigo Scientific Announces the Launch of Extra Large Drying Traps

    Jun 27, 2022, 10:46 AM by
    Amerigo Scientific introduces new extra large Drying Traps for research application.
    Full story
  • Global Active Pharmaceutical Ingredients Market Is Expected To Grow With The CAGR Of More Than 6.8% By 2027

    Jun 24, 2022, 09:22 AM by
    Global Active Pharmaceeutical Ingredients Market size, share, trends, growth, opportunity, forecast
    Full story
  • 5th Edition of World Nanotechnology Conference

    Jun 24, 2022, 09:20 AM by
    Full story
  • CD BioSciences Announces Solubilization and Stabilization Solution to Simplify GPCR Research

    Jun 24, 2022, 09:17 AM by
    CD BioSciences introduces GPCR solubilization and stabilization services to researchers to advance scientific programs in GPCR research and drug development.
    Full story
  • STEMart Launches Microbiology & Sterility Testing Services for Medical Devices

    Jun 24, 2022, 09:17 AM by
    STEMart introduces comprehensive microbiology and sterility testing for sterile, non-pyrogenic products.
    Full story
  • Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

    Jun 24, 2022, 09:17 AM by
    Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy.
    Full story
  • Jumo Health Helps Young People to Become Effective Patient Advocates

    Jun 23, 2022, 09:14 AM by
    Jumo Health, a global provider of age appropriate, culturally sensitive, medical education resources, today announced that it is extending its ongoing support of the International Children’s Advisory Network (iCAN), a global consortium of youth advisory groups. iCAN empowers pediatric patients worldwide and provides a voice for children and their families in healthcare, clinical trials, and medical research.
    Full story
  • ‘Chemical Thermometer’ Factors In Local Environment Of A Cobalt Molecule

    Jun 23, 2022, 01:00 AM by User Not Found
    Bio-IT World | A cobalt-based molecule engineered to be a noninvasive chemical thermometer for detecting tiny temperature changes, one of the signposts of injury and disease as well as the true edges of a cancerous tumor, opens the door to a new approach where the mimicking is focused on manipulating a molecule’s quantum aspects rather than its reactivity, according to Joseph Zadrozny, assistant professor of chemistry at Colorado State University.
    Full story
  • Fuel Cell Catalysts for Renewable Energy Industry

    Jun 22, 2022, 09:11 AM by
    Full story
  • CD Formulation Enables Customized Synthesis Service for Osmotic Pressure Regulators

    Jun 22, 2022, 09:11 AM by
    Normal cell function requires the maintenance of osmotic pressure. Therefore, in drug manufacturing, osmotic pressure regulators should be added to the formulation to avoid tissue damage. The US-based CRO company CD Formulation recently announced its ability to synthesize osmotic pressure regulators to suit the needs of different drug projects. These osmotic pressure regulators will help parenteral preparations to keep isotonic with human plasma.
    Full story
  • Creative Enzymes Introduces DNA Modifying Enzymes for Molecular Biology Research

    Jun 22, 2022, 09:11 AM by
    Full story
  • Creative Enzymes Expands Its Service Offering with the Launch of Native Horseradish Peroxidase

    Jun 22, 2022, 09:11 AM by
    Full story
  • mdgroup Proudly Sponsors Gladiator Project Spring Classic Golf Fundraiser to Raise Awareness and Hope for Brain Cancer Research and Support

    Jun 22, 2022, 09:10 AM by
    mdgroup Proudly Sponsors Gladiator Project Spring Classic Golf Fundraiser to Raise Awareness and Hope for Brain Cancer Research and Support Durham, NC, USA – 21 June 2022 – mdgroup, the global digital and patient servicing company pioneering a patient-first approach to clinical research, is proud to sponsor brain cancer research and patient support group, Gladiator Project, with its upcoming Spring Classic golf tournament in the USA. Taking place in New Jersey on June 27 at the Plainfield Country Club in Edison, the sporting event will attract audiences from the patient advocacy community, as well as the research industry, including mdgroup Chief Operating Officer, LaQuinta Jernigan.
    Full story
  • ZeOmega Announces Agreement with HealPros to Optimize In-Home Experiences for People with Chronic Illness: ZeOmega’s Jiva Platform to Support HealPros New In-Home Program Deployment

    Jun 22, 2022, 09:10 AM by
    ZeOmega®, the leading population health management organization, has partnered with HealPros, a healthcare services company that works with some of the largest health plans in the nation to build and deliver programs that change the lives of people with chronic illnesses. This partnership will yield significant results for health plans and their members by helping them access personalized care and delivering in-home experiences people love.
    Full story
  • Ultrasound May Become Alternative To Antidiabetic Drugs

    Jun 22, 2022, 01:00 AM by User Not Found
    Bio-IT World | Using ultrasound to stimulate neurometabolic pathways in the body to prevent or reverse type 2 diabetes is a centerpiece of research and development efforts at the General Electric (GE) Research Center in Niskayuna, NY.
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136 (current)
  • 137
  • 138
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy